Avoid this common investment mistake with these 3 dividend-paying stocks

Charlie Munger has some timely advice for investors.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

One of the more unusual and exciting aspects to sharemarket investing is the constant need to remain grounded and aware of your own psychological tendencies. The need to understand human nature in the context of investing is not new; indeed Warren Buffett's long-time investment partner Charlie Munger gave a lecture in 1995 entitled "The Psychology of Human Misjudgement"!

As value investors know, it is precisely because of human nature that many wonderful investment opportunities arise. One example of human nature in action is the tendency to extrapolate the recent past into the future. This can lead to investors paying an enormous premium for a stock which has historically grown quickly on the assumption that the growth rate will continue indefinitely into the future; alternatively it can lead to the discounting of a stock because of a recent past event which may lead to an unduly pessimistic view of future performance.

Look forward not backwards

One way to potentially benefit from this trait which afflicts many investors is to analyse high-yielding stocks. Often a historically high quoted yield suggests the market has little faith in the future dividend to be paid. While the market will regularly get this assessment right, there are also times when investors can utilise the market's misjudgement to scoop up truly high yielding opportunities.

Metcash Limited (ASX: MTS) is trading near its 52-week low after having disappointed the market with its earnings outlook. While earnings growth may be some time off, analyst consensus provided by Morningstar forecast the dividend to rise in 2016, implying a fully franked yield of 5.9%.

Insurance Australia Group Limited (ASX: IAG) is not forecast to achieve much growth in 2015 but the dividend is forecast to rise by 2.2%. The stock is trading on a forecast fully franked yield of 6.1%.

Coca-Cola Amatil Ltd (ASX: CCL) has also been shunned by investors recently due to a forecast decline in earnings and dividends in FY 2014. By FY 2015 however, earnings and dividends are expected to begin to recover with the stock forecast to yield 5.3%.

Motley Fool contributor Tim McArthur does not own shares in any of the companies mentioned in this article.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »